News
Greedy accumulation-directed evolution generated multi-site combinatorial mutants of T7 RNA polymerase (T7 RNAP), breaking ...
Researchers conducted a retrospective study published in July 2025 issue of Journal of Hematology & Oncology to examine the ...
A new drug was shown to significantly reduce tumor growth in lab studies by up to 77% for melanoma and colorectal cancers.
Laiho holds patents on RNA polymerase 1 inhibitors, which are managed by The Johns Hopkins University in accordance with its conflict-of-interest policies. Source: Johns Hopkins Medicine.
5d
News-Medical.Net on MSNTargeting tumor cell stemness may hold the key to treating colon cancer more effectivelyColon cancer remains a major global health concern, ranking third among the most diagnosed cancers and leading causes of ...
What am I looking at? This is a 3D rendering of an RNA polymerase II enzyme from baker’s yeast, created using actual molecular data to reconstruct its shape and active sites. What looks like a ...
A significant percentage of patients with SSc first present with non-RP symptoms — most commonly puffy fingers/hands — and are associated with more severe disease.
In addition to its newly launched CleanScribe RNA Polymerase, TriLink offers mRNA capping analogs (including the award-winning CleanCap® M6), mRNA raw materials (nucleotides and other IVT enzymes ...
DNA polymerase was isolated in 1956; RNA polymerase, in 1959. Wave Life Sciences, a clinical-stage RNA medicines company, develops A-to-I RNA base editing oligonucleotides (“AIMers”).
Instead, hepatitis D virus hijacks the cellular DNA-dependent RNA polymerase II (Pol-II), normally used to produce messenger RNAs from genomic DNA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results